Cargando…

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy

Objectives: This study aimed to investigate the unique prognostic, clinical, and renal histopathological characteristics of patients with idiopathic membranous nephropathy (IMN) with different levels of proteinuria. Methods: This retrospective observational study included 190 IMN patients with low l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinxin, Chen, Yu, Ding, Xiaokai, Zhou, Ying, Lv, Yinqiu, Li, Duo, Chen, Bo, Chen, Tianxin, Chen, Chaosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508055/ https://www.ncbi.nlm.nih.gov/pubmed/31057017 http://dx.doi.org/10.1080/0886022X.2019.1605294

Ejemplares similares

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome
por: Chen, Tianxin, et al.
Publicado: (2021)

Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study
por: Hu, Ya, et al.
Publicado: (2023)

Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis
por: Li, Zhenzhou, et al.
Publicado: (2023)

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
por: Sun, Mengyao, et al.
Publicado: (2023)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Elevated serum fibrinogen level is an independent risk factor for IgA nephropathy
por: Zhang, Ji, et al.
Publicado: (2017)

Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan
por: Yamaguchi, Makoto, et al.
Publicado: (2018)

Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy
por: Lee, Su Mi, et al.
Publicado: (2015)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

High (≥6.5) Spontaneous and Persistent Urinary pH Is Protective of Renal Function at Baseline and during Disease Course in Idiopathic Membranous Nephropathy
por: Bazzi, Claudio, et al.
Publicado: (2015)

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study
por: Shu, Danhua, et al.
Publicado: (2017)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
por: Liang, Jinxiu, et al.
Publicado: (2023)

Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis
por: Chen, Miaomiao, et al.
Publicado: (2022)

Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy
por: Zhang, Wei, et al.
Publicado: (2019)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction
por: Wang, Peiheng, et al.
Publicado: (2023)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
por: Tumlin, J. A., et al.
Publicado: (2013)

Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
por: Chen, Yizhen, et al.
Publicado: (2022)

Clinicopathological and prognostic study of IgA-dominant postinfectious glomerulonephritis
por: Huang, Ziyuan, et al.
Publicado: (2021)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials
por: Huang, Haiting, et al.
Publicado: (2021)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
por: Li, Zhe, et al.
Publicado: (2023)

Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
por: Kumar, Sanjeev, et al.
Publicado: (2012)

Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury
por: Chen, Tianxin, et al.
Publicado: (2022)

A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China
por: Wu, Lianzhong, et al.
Publicado: (2021)

Statins can benefit patients with primary membranous nephropathy on venous thromboembolism
por: Zou, Peimei, et al.
Publicado: (2021)

Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study
por: Zhao, Yuchao, et al.
Publicado: (2022)

Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study
por: Zhang, Shasha, et al.
Publicado: (2022)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

Combination of the gut microbiota and clinical indicators as a potential index for differentiating idiopathic membranous nephropathy and minimal change disease
por: Jiang, Yumin, et al.
Publicado: (2023)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1mc6845kano7a4u0ustqhmrah